Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs
Concerns have been raised over the supply of vital testing materials for a range of conditions, including Covid-19, following a supply chain problem with the pharmaceutical company Roche.
On Tuesday, Roche said it had experienced a “very significant drop” in its processing capacity due to a problem with its Sussex distribution centre, the only one in the UK. It has been reported that the shortage includes vital reagents, screening kits and swabs.
Related: UK government ‘thwarting independent labs’ efforts to step up Covid-19 testing’
